With the Moderna (NASDAQ:MRNA) share price blasting up, have the forward-looking markets got it right?

The Moderna (NASDAQ: MRNA) share price is going gangbusters as the world awaits results of its COVID-19 vaccine trial. Let's take a look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Moderna Inc (NASDAQ: MRNA) share price went like gangbusters yesterday, overnight Aussie time. The US biotech company's share price leapt 10.8%. And its up another 3.8% in afterhours trading.

This comes as investors eagerly anticipate the outcome of the final analysis of Moderna's promising COVID-19 vaccine trial.

Earlier this month, Moderna joined Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) in a globally exclusive club when the company announced its vaccine looked to be 95% effective in its extensive trial. One which encompassed 30,000 people.

Moderna's share price is now up 62% so far in November, and 468% so far in 2020. At the current share price, Moderna has a market cap of $48 billion.

small figure representing ASX shares with cape and shield fighting coronavirus

Image source: Getty Images

What does Moderna do?

Based in the United States city of Cambridge, Massachusetts, Moderna is a biotechnology company. The company focuses on developing and discovering new drugs and vaccine technologies based on messenger RNA. Moderna's technology platform inserts synthetic mRNA into human cells.

Why did the Moderna's share price leap 11% overnight?

Moderna's share price has been steadily moving higher on a series of positive announcements from the company.

Among those, the US has committed to buying 100 million doses of its vaccine, mRNA-1273, provided it wins emergency use approval. And it's not just the US.

Japan has agreed to buy 50 million doses, Canada wants 20 million and, in the latest development, the European Commission agreed to buy 80 million doses with an option to double that to 160 million. That agreement remains subject to European approval of the vaccine.

The 10.8% share price leap overnight comes as Moderna expects to release the final data from its expansive trial within the next week. Should the vaccine's efficacy prove to be in the 94.5% range as initially reported, Moderna will then file for emergency use authorisation with the US Food and Drug Administration (FDA).

If it gains approval, Moderna's vaccine could begin mass distribution just as global infection rates are rocketing to new levels. Hence the big share price surge.

Share markets are said to be forward looking. Meaning they anticipate tomorrow's news today.

With more than 588,000 new infections reported on Tuesday, 24 March, and global cases exceeding 60.2 million with 1.4 million fatalities, let's all hope the market's got this one right!

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

A woman's hand draws a stylised 'Top Ten' on a projected surface.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a very unhappy hump day on the markets.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Ampol, Meteoric Resources, Praemium, and Treasury Wine shares are storming higher

These shares are having a better day than most on hump day. But why?

Read more »

A close up of a casino card dealer's hands shuffling a deck of cards at a professional gambling table with the eager faces of casino patrons in the background.
Share Gainers

Why is everyone buying Tabcorp shares this week?

Here's what is driving the latest price momentum for Tabcorp shares, and what to expect next.

Read more »

A group of people clink wine glasses in an outdoor, late afternoon setting to celebrate the rising Treasury Wine share price
Consumer Staples & Discretionary Shares

Why are Treasury Wine shares rocketing 16% today?

Investors are piling into Treasury Wine shares on Wednesday. But why?

Read more »

A team of people giving the thumbs up sign.
Share Gainers

This ASX 200 stock has jumped 149% in a year, and brokers tip more upside to come

The business has experienced huge demand across both of its two core business segments.

Read more »

Woman sitting at a desk shrugs.
Share Gainers

Up over 70% in a month, is it too late to buy Zip shares?

Zip shares keep climbing higher, is there any more upside left?

Read more »

Girl with painted hands.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a disappointing Tuesday for investors.

Read more »